Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis

Koca, Süleyman SerdarÖz, BurakKarataş, AhmetCan, GercekŞenel, SonerYazıcı, Aytenİnanç, NevsunCefle, AyşeErtürk, ZeynepAkar, ServetGöker, BernaBirlik, MerihÖnen, Fatoş2023-11-102023-11-102018-06Koca, S. S. vd. (2018). ''Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis''. Annals of the Rheumatic Diseases, 77(Supplement 2), 597-597.0003-49671468-2060https://doi.org/10.1136/annrheumdis-2018-eular.5819https://ard.bmj.com/content/77/Suppl_2/597.1http://hdl.handle.net/11452/34832Bu çalışma, 13-16, Haziran 2018 tarihlerinde Amsterdam[Hollanda]’da düzenlenen Congress of the European-League-Against-Rheumatism (EULAR) Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/openAccessRheumatologyConcomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritisMeeting Abstract00044435100156859759777Supplement 2Rheumatology